山东大学耳鼻喉眼学报 ›› 2021, Vol. 35 ›› Issue (2): 98-104.doi: 10.6040/j.issn.1673-3770.0.2020.358
赵良慧1,2,蔡涛2,杜显丽2
ZHAO Lianghui1,2, CAI Tao2, DU Xianli2
摘要: 目的 分析圆锥角膜男性患者的临床表型及致病基因突变,寻找致病基因突变位点,探讨表型与基因型之间的关系。 方法 收集1例圆锥角膜男性患者及其父母的临床资料,完善其眼科检查,用Pentacam角膜地形图及生物力学分析提高疾病诊断。提取该家系中全部成员的外周血基因组DNA,选取先证者进行全外显子组测序,最终通过家系内共分离验证致病突变,进一步分析该突变与患者表型间的关系。 结果 患者被诊断为圆锥角膜初发期,其父亲被诊断为圆锥角膜完成期。全外显子组测序发现先证者的锌指转录因子(ZEB1)基因c.643G>C突变,该突变导致了ZEB1基因所编码蛋白第215位氨基酸由缬氨酸变为亮氨酸(p.V215L)。保守性分析显示该突变在各物种中高度保守,生物信息学预测结果表明该突变具有较高的致病性。该基因的突变亦存在于其父亲基因中。先证者的母亲临床表现正常,该突变在先证者的母亲和100个不相关的正常对照中不存在。 结论 临床检查结果表明该家系内先证者及其父亲均符合典型的圆锥角膜表型,全外显子组测序发现了ZEB1基因上一个错义突变(c.643G>C),该突变在家系内共分离。
中图分类号:
[1] Mas Tur V, MacGregor C, Jayaswal R, et al. A review of keratoconus: Diagnosis, pathophysiology, and genetics[J]. Surv Ophthalmol, 2017, 62(6): 770-783. doi:10.1016/j.survophthal.2017.06.009. [2] Gordon-Shaag A, Millodot M, Shneor E, et al. The genetic and environmental factors for keratoconus[J]. Biomed Res Int, 2015, 2015: 1-19. doi:10.1155/2015/795738. [3] Davidson AE, Hayes S, Hardcastle AJ, et al. The pathogenesis of keratoconus[J]. Eye, 2014, 28(2): 189-195. doi:10.1038/eye.2013.278. [4] Rabinowitz YS. Keratoconus[J]. Surv Ophthalmol, 1998, 42(4): 297-319. doi:10.1016/s0039-6257(97)00119-7. [5] Wang Y, Rabinowitz YS, Rotter JI, et al. Genetic epidemiological study of keratoconus: evidence for major gene determination[J]. Am J Med Genet, 2000, 93(5): 403-409. doi:10.1002/1096-8628(20000828)93:5. [6] Tuft SJ, Hassan H, George S, et al. Keratoconus in 18 pairs of twins[J]. Acta Ophthalmol, 2012, 90(6): e482-e486. doi:10.1111/j.1755-3768.2012.02448.x. [7] Hansen MC, Haferlach T, Nyvold CG. A decade with whole exome sequencing in haematology[J]. Br J Haematol, 2020, 188(3): 367-382. doi:10.1111/bjh.16249. [8] Jelin AC, Vora N. Whole exome sequencing: applications in prenatal genetics[J]. Obstet Gynecol Clin North Am, 2018, 45(1): 69-81. doi:10.1016/j.ogc.2017.10.003. [9] Gomes JAP, Tan D, Rapuano CJ, et al. Global consensus on keratoconus and ectatic diseases[J]. Cornea, 2015, 34(4): 359-369. doi:10.1097/ico.0000000000000408. [10] 中华医学会眼科学分会角膜病学组. 中国圆锥角膜诊断和治疗专家共识(2019年)[J]. 中华眼科杂志, 2019, 55(12): 891-895. doi:10.3760/cma.j.issn.0412-4081.2019.12.004. [11] Ambrósio R Jr, Caiado ALC, Guerra FP, et al. Novel pachymetric parameters based on corneal tomography for diagnosing keratoconus[J]. J Refract Surg, 2011, 27(10): 753-758. doi:10.3928/1081597x-20110721-01. [12] Cankaya C, Gunduz A, Cumurcu T, et al. Familial association of keratoconus and granular corneal dystrophy: the familial case series[J]. North Clin Istanbul, 2018, 6(2): 176-183. doi:10.14744/nci.2018.08860. [13] Shapiro MB, France TD. The ocular features of Down's syndrome[J]. Am J Ophthalmol, 1985, 99(6): 659-663. doi:10.1016/s0002-9394(14)76031-3. [14] Umale RH, Khan MA, Moulick PS, et al. A clinical study to describe the corneal topographic pattern and estimation of the prevalence of keratoconus among diagnosed cases of vernal keratoconjunctivitis[J]. Med J Armed Forces India, 2019, 75(4): 424-428. doi:10.1016/j.mjafi.2018.07.012. [15] Ionescu IC, Corbu CG, Nicula C, et al. The importance of corneal biomechanics in assessing first degree family members of keratoconus patients[J]. Rom J Ophthalmol, 2018, 62(2): 149-154. [16] Caramel J, Ligier M, Puisieux A. Pleiotropic roles for ZEB1 in cancer[J]. Cancer Res, 2018, 78(1): 30-35. doi:10.1158/0008-5472.can-17-2476. [17] Cortés M, Sanchez-Moral L, de Barrios O, et al. Tumor-associated macrophages(TAMs)depend on ZEB1 for their cancer-promoting roles[J]. EMBO J, 2017, 36(22): 3336-3355. doi:10.15252/embj.201797345. [18] Lee J, Jung E, Gestoso K, et al. ZEB1 mediates fibrosis in corneal endothelial mesenchymal transition through SP1 and SP3[J]. Invest Ophthalmol Vis Sci, 2020, 61(8): 41. doi:10.1167/iovs.61.8.41. [19] Lee J, Jung E, Heur M. Injury induces endothelial to mesenchymal transition in the mouse corneal endothelium in vivo via FGF2[J]. Mol Vis, 2019, 25: 22-34. [20] Gupta R, Kumawat BL, Paliwal P, et al. Association of ZEB1 and TCF4 rs613872 changes with late onset Fuchs endothelial corneal dystrophy in patients from northern India[J]. Mol Vis, 2015, 21: 1252-1260. [21] Frausto RF, Chung DD, Boere PM, et al. ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing[J]. PLoS One, 2019, 14(6): e0218279. doi:10.1371/journal.pone.0218279. [22] Tang H, Zhang W, Yan XM, et al. Analysis of SLC4A11, ZEB1, LOXHD1, COL8A2 and TCF4 gene sequences in a multi-generational family with late-onset Fuchs corneal dystrophy[J]. Int J Mol Med, 2016, 37(6): 1487-1500. doi:10.3892/ijmm.2016.2570. [23] Bakhtiari P, Frausto RF, Roldan AN, et al. Exclusion of pathogenic promoter region variants and identification of novel nonsense mutations in the zinc finger E-box binding homeobox 1 gene in posterior polymorphous corneal dystrophy[J]. Mol Vis, 2013, 19: 575-580. [24] Chung DW, Frausto RF, Ann LB, et al. Functional impact of ZEB1Mutations associated with posterior polymorphous and fuchs' endothelial corneal dystrophies[J]. Invest Ophthalmol Vis Sci, 2014, 55(10): 6159. doi:10.1167/iovs.14-15247. [25] Chung DW, Frausto RF, Chiu S, et al. Investigating the molecular basis of PPCD3: characterization of ZEB1 regulation of COL4A3 expression[J]. Invest Ophthalmol Vis Sci, 2016, 57(10): 4136. doi:10.1167/iovs.16-19533. [26] Liskova P, Evans CJ, Davidson AE, et al. Heterozygous deletions at the ZEB1 locus verify haploinsufficiency as the mechanism of disease for posterior polymorphous corneal dystrophy type 3[J]. Eur J Hum Genet, 2016, 24(7): 985-991. doi:10.1038/ejhg.2015.232. [27] Cunnusamy K, Bowman CB, Beebe W, et al. Congenital corneal endothelial dystrophies resulting from novel de novo mutations[J]. Cornea, 2016, 35(2): 281-285. doi:10.1097/ico.0000000000000670. [28] Rao BS, Ansar S, Arokiasamy T, et al. Analysis of candidate genes ZEB1 and LOXHD1 in late-onset Fuchs’ endothelial corneal dystrophy in an Indian cohort[J]. Ophthalmic Genet, 2018, 39(4): 443-449. doi:10.1080/13816810.2018.1474367. [29] Dudakova L, Skalicka P, Davidson AE, et al. Coincidental occurrence of schnyder corneal dystrophy and posterior polymorphous corneal dystrophy type 3[J]. Cornea, 2019, 38(6): 758-760. doi:10.1097/ico.0000000000001930. [30] Chung DD, Frausto RF, Lin BR, et al. Transcriptomic profiling of posterior polymorphous corneal dystrophy[J]. Invest Ophthalmol Vis Sci, 2017, 58(7): 3202-3214. doi:10.1167/iovs.17-21423. [31] Evans CJ, Liskova P, Dudakova L, et al. Identification of six novel mutations in ZEB1and description of the associated phenotypes in patients with posterior polymorphous corneal dystrophy 3[J]. Ann Hum Genet, 2015, 79(1): 1-9. doi:10.1111/ahg.12090. [32] Bykhovskaya Y, Margines B, Rabinowitz YS. Genetics in Keratoconus: where are we?[J]. Eye Vis(Lond), 2016, 3: 16. doi:10.1186/s40662-016-0047-5. |
[1] | 王传玉,牟国营. 圆锥角膜合并K-F环1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2022, 36(5): 58-62. |
[2] | 黄天泽,陈迪,李莹. 机器学习在眼表疾病诊断及角膜手术中的应用进展[J]. 山东大学耳鼻喉眼学报, 2021, 35(6): 13-19. |
[3] | 夏艳云,钟定娟,王华,李孟婷,李前,陈蛟,何书喜. 高能量加速型角膜胶原交联术对圆锥角膜眼表的影响[J]. 山东大学耳鼻喉眼学报, 2021, 35(6): 42-51. |
[4] | 张斌,李威,何伟. 大气泡法辅助深板层角膜移植治疗圆锥角膜的临床观察[J]. 山东大学耳鼻喉眼学报, 2021, 35(1): 92-94. |
[5] | 张晓,姜良柱,徐艳云,牟国营. 等渗与低渗核黄素诱导的角膜交联术治疗圆锥角膜的疗效观察[J]. 山东大学耳鼻喉眼学报, 2016, 30(2): 87-90. |
[6] | 张春晓, 李志伟, 徐文文, 李凤娇, 陶祥臣, 牟国营. 核黄素/UVA诱导的角膜交联术治疗晚期圆锥角膜的安全性和有效性[J]. 山东大学耳鼻喉眼学报, 2015, 29(2): 86-88. |
[7] | 胡 明,李招娜,李云杰,陶祥臣 . 硬性透气性角膜接触镜对圆锥角膜的塑形作用[J]. 山东大学耳鼻喉眼学报, 2007, 21(2): 171-173 . |
|